Daiwa Securities Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6K Hold
357
﹤0.01% 1149
2025
Q1
$6K Hold
357
﹤0.01% 1124
2024
Q4
$11K Sell
357
-65
-15% -$2K ﹤0.01% 1113
2024
Q3
$7K Sell
422
-4,620
-92% -$76.6K ﹤0.01% 1152
2024
Q2
$87K Sell
5,042
-80
-2% -$1.38K ﹤0.01% 1031
2024
Q1
$80K Buy
5,122
+4,700
+1,114% +$73.4K ﹤0.01% 1064
2023
Q4
$6K Hold
422
﹤0.01% 1187
2023
Q3
$7K Sell
422
-9,766
-96% -$162K ﹤0.01% 1134
2023
Q2
$423K Sell
10,188
-1,231
-11% -$51.1K ﹤0.01% 851
2023
Q1
$686K Buy
11,419
+191
+2% +$11.5K ﹤0.01% 746
2022
Q4
$824K Sell
11,228
-415
-4% -$30.5K 0.01% 694
2022
Q3
$884K Sell
11,643
-278
-2% -$21.1K 0.01% 673
2022
Q2
$829K Buy
11,921
+1,951
+20% +$136K 0.01% 704
2022
Q1
$826K Buy
9,970
+1,981
+25% +$164K 0.01% 749
2021
Q4
$600K Buy
7,989
+487
+6% +$36.6K ﹤0.01% 825
2021
Q3
$871K Sell
7,502
-1,886
-20% -$219K 0.01% 714
2021
Q2
$2.08M Sell
9,388
-340
-3% -$75.4K 0.01% 440
2021
Q1
$1.29M Buy
9,728
+3,916
+67% +$518K 0.01% 544
2020
Q4
$1.01M Buy
5,812
+827
+17% +$143K 0.01% 570
2020
Q3
$554K Buy
4,985
+4,426
+792% +$492K 0.01% 667
2020
Q2
$32K Hold
559
﹤0.01% 955
2020
Q1
$38K Hold
559
﹤0.01% 962
2019
Q4
$41K Sell
559
-66
-11% -$4.84K ﹤0.01% 965
2019
Q3
$47K Buy
625
+21
+3% +$1.58K ﹤0.01% 951
2019
Q2
$38K Hold
604
﹤0.01% 971
2019
Q1
$29K Buy
604
+110
+22% +$5.28K ﹤0.01% 968
2018
Q4
$17K Hold
494
﹤0.01% 965
2018
Q3
$26K Hold
494
﹤0.01% 977
2018
Q2
$15K Hold
494
﹤0.01% 1013
2018
Q1
$11K Buy
+494
New +$11K ﹤0.01% 1016